Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Macrophage ferroportin is essential for stromal cell proliferation in wound healing.

Recalcati S, Gammella E, Buratti P, Doni A, Anselmo A, Locati M, Cairo G.

Haematologica. 2019 Jan;104(1):47-58. doi: 10.3324/haematol.2018.197517. Epub 2018 Aug 16.

2.

Dysregulation of iron metabolism in cancer stem cells.

Recalcati S, Gammella E, Cairo G.

Free Radic Biol Med. 2018 Jul 21. pii: S0891-5849(18)31259-0. doi: 10.1016/j.freeradbiomed.2018.07.015. [Epub ahead of print]

PMID:
30040994
3.

Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells.

Raggi C, Gammella E, Correnti M, Buratti P, Forti E, Andersen JB, Alpini G, Glaser S, Alvaro D, Invernizzi P, Cairo G, Recalcati S.

Sci Rep. 2017 Dec 15;7(1):17667. doi: 10.1038/s41598-017-17804-1.

4.

The transferrin receptor: the cellular iron gate.

Gammella E, Buratti P, Cairo G, Recalcati S.

Metallomics. 2017 Oct 18;9(10):1367-1375. doi: 10.1039/c7mt00143f. Review.

PMID:
28671201
5.

Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis.

Rybinska I, Cairo G.

Vitam Horm. 2017;105:143-160. doi: 10.1016/bs.vh.2017.01.001. Epub 2017 Mar 15. Review.

PMID:
28629515
6.

Molecular regulation of cellular iron balance.

Recalcati S, Gammella E, Buratti P, Cairo G.

IUBMB Life. 2017 Jun;69(6):389-398. doi: 10.1002/iub.1628. Epub 2017 May 7. Review.

7.

Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.

Ciccarese M, Fabi A, Moscetti L, Cazzaniga ME, Petrucelli L, Forcignanò R, Lupo LI, De Matteis E, Chiuri VE, Cairo G, Febbraro A, Giordano G, Giampaglia M, Bilancia D, La Verde N, Maiello E, Morritti M, Giotta F, Lorusso V, Latorre A, Scavelli C, Romito S, Cusmai A, Palmiotti G, Surico G.

Breast Cancer Res Treat. 2017 Jun;163(3):587-594. doi: 10.1007/s10549-017-4213-9. Epub 2017 Mar 28.

PMID:
28353061
8.

New perspectives on the molecular basis of the interaction between oxygen homeostasis and iron metabolism.

Recalcati S, Gammella E, Cairo G.

Hypoxia (Auckl). 2015 Dec 11;3:93-103. eCollection 2015. Review.

9.

Soft TCPTP Agonism-Novel Target to Rescue Airway Epithelial Integrity by Exogenous Spermidine.

Ghisalberti CA, Borzì RM, Cetrullo S, Flamigni F, Cairo G.

Front Pharmacol. 2016 Jun 3;7:147. doi: 10.3389/fphar.2016.00147. eCollection 2016.

10.

Dual Role of ROS as Signal and Stress Agents: Iron Tips the Balance in favor of Toxic Effects.

Gammella E, Recalcati S, Cairo G.

Oxid Med Cell Longev. 2016;2016:8629024. doi: 10.1155/2016/8629024. Epub 2016 Feb 24. Review.

11.

Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms.

Gammella E, Recalcati S, Rybinska I, Buratti P, Cairo G.

Oxid Med Cell Longev. 2015;2015:230182. doi: 10.1155/2015/230182. Epub 2015 Mar 24. Review.

12.

High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload.

Dongiovanni P, Lanti C, Gatti S, Rametta R, Recalcati S, Maggioni M, Fracanzani AL, Riso P, Cairo G, Fargion S, Valenti L.

PLoS One. 2015 Feb 3;10(2):e0116855. doi: 10.1371/journal.pone.0116855. eCollection 2015. Erratum in: PLoS One. 2015;10(3):e0120457.

13.

Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly.

Gammella E, Diaz V, Recalcati S, Buratti P, Samaja M, Dey S, Noguchi CT, Gassmann M, Cairo G.

Am J Physiol Regul Integr Comp Physiol. 2015 Feb 15;308(4):R330-5. doi: 10.1152/ajpregu.00410.2014. Epub 2014 Dec 17.

14.

Recent Advances in Iron Metabolism: Relevance for Health, Exercise, and Performance.

Buratti P, Gammella E, Rybinska I, Cairo G, Recalcati S.

Med Sci Sports Exerc. 2015 Aug;47(8):1596-604. doi: 10.1249/MSS.0000000000000593.

PMID:
25494391
15.

Macrophages: central regulators of iron balance.

Gammella E, Buratti P, Cairo G, Recalcati S.

Metallomics. 2014 Aug;6(8):1336-45. doi: 10.1039/c4mt00104d. Review.

16.

Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity.

Maccarinelli F, Gammella E, Asperti M, Regoni M, Biasiotto G, Turco E, Altruda F, Lonardi S, Cornaghi L, Donetti E, Recalcati S, Poli M, Finazzi D, Arosio P, Cairo G.

J Mol Med (Berl). 2014 Aug;92(8):859-69. doi: 10.1007/s00109-014-1147-0. Epub 2014 Apr 13.

17.

The role of iron in anthracycline cardiotoxicity.

Gammella E, Maccarinelli F, Buratti P, Recalcati S, Cairo G.

Front Pharmacol. 2014 Feb 26;5:25. doi: 10.3389/fphar.2014.00025. eCollection 2014. Review.

18.

Potent trophic activity of spermidine supramolecular complexes in in vitro models.

Ghisalberti CA, Morisetti A, Bestetti A, Cairo G.

World J Biol Chem. 2013 Aug 26;4(3):71-8. doi: 10.4331/wjbc.v4.i3.71.

19.

Liver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice.

Díaz V, Gammella E, Recalcati S, Santambrogio P, Naldi AM, Vogel J, Gassmann M, Cairo G.

Hepatology. 2013 Dec;58(6):2122-32. doi: 10.1002/hep.26550. Epub 2013 Oct 21.

PMID:
23744538
20.

Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.

Robach P, Recalcati S, Girelli D, Campostrini N, Kempf T, Wollert KC, Corbella M, Santambrogio P, Perbellini L, Brasse-Lagnel C, Christensen B, Moutereau S, Lundby C, Cairo G.

Eur J Haematol. 2013 Jul;91(1):74-84. doi: 10.1111/ejh.12122. Epub 2013 May 3.

PMID:
23582009
21.

Dietary iron overload induces visceral adipose tissue insulin resistance.

Dongiovanni P, Ruscica M, Rametta R, Recalcati S, Steffani L, Gatti S, Girelli D, Cairo G, Magni P, Fargion S, Valenti L.

Am J Pathol. 2013 Jun;182(6):2254-63. doi: 10.1016/j.ajpath.2013.02.019. Epub 2013 Apr 8.

PMID:
23578384
22.

Systemic and cellular consequences of macrophage control of iron metabolism.

Recalcati S, Locati M, Cairo G.

Semin Immunol. 2012 Dec;24(6):393-8. doi: 10.1016/j.smim.2013.01.001. Epub 2013 Jan 30. Review.

PMID:
23375134
23.

Iron levels in polarized macrophages: regulation of immunity and autoimmunity.

Recalcati S, Locati M, Gammella E, Invernizzi P, Cairo G.

Autoimmun Rev. 2012 Oct;11(12):883-9. doi: 10.1016/j.autrev.2012.03.003. Epub 2012 Mar 16. Review.

PMID:
22449938
24.

Setup for human sera MALDI profiling: the case of rhEPO treatment.

Fania C, Vasso M, Torretta E, Robach P, Cairo G, Lundby C, Gelfi C.

Electrophoresis. 2011 Jun;32(13):1715-27. doi: 10.1002/elps.201100134.

25.

Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype.

Cairo G, Recalcati S, Mantovani A, Locati M.

Trends Immunol. 2011 Jun;32(6):241-7. doi: 10.1016/j.it.2011.03.007. Epub 2011 Apr 21.

PMID:
21514223
26.

Role of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity.

Spagnuolo RD, Recalcati S, Tacchini L, Cairo G.

Br J Pharmacol. 2011 May;163(2):299-312. doi: 10.1111/j.1476-5381.2011.01208.x.

27.

Iron regulatory proteins: from molecular mechanisms to drug development.

Recalcati S, Minotti G, Cairo G.

Antioxid Redox Signal. 2010 Nov 15;13(10):1593-616. doi: 10.1089/ars.2009.2983. Review.

PMID:
20214491
28.

Adenosine A(2)A receptor but not HIF-1 mediates Tyrosine hydroxylase induction in hypoxic PC12 cells.

Gammella E, Cairo G, Tacchini L.

J Neurosci Res. 2010 Jul;88(9):2007-16. doi: 10.1002/jnr.22366.

PMID:
20143408
29.

Differential regulation of iron homeostasis during human macrophage polarized activation.

Recalcati S, Locati M, Marini A, Santambrogio P, Zaninotto F, De Pizzol M, Zammataro L, Girelli D, Cairo G.

Eur J Immunol. 2010 Mar;40(3):824-35. doi: 10.1002/eji.200939889.

30.

Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.

Dongiovanni P, Fracanzani AL, Cairo G, Megazzini CP, Gatti S, Rametta R, Fargion S, Valenti L.

Am J Pathol. 2010 Feb;176(2):1006-17. doi: 10.2353/ajpath.2010.090249. Epub 2009 Dec 17.

31.

Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.

Robach P, Recalcati S, Girelli D, Gelfi C, Aachmann-Andersen NJ, Thomsen JJ, Norgaard AM, Alberghini A, Campostrini N, Castagna A, Viganò A, Santambrogio P, Kempf T, Wollert KC, Moutereau S, Lundby C, Cairo G.

Blood. 2009 Jun 25;113(26):6707-15. doi: 10.1182/blood-2008-09-178095. Epub 2009 Mar 4.

32.

A precious metal: Iron, an essential nutrient for all cells.

Cairo G, Bernuzzi F, Recalcati S.

Genes Nutr. 2006 Mar;1(1):25-39. doi: 10.1007/BF02829934.

33.

Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: role for heme oxygenase-1 down-modulation.

Bernuzzi F, Recalcati S, Alberghini A, Cairo G.

Chem Biol Interact. 2009 Jan 15;177(1):12-20. doi: 10.1016/j.cbi.2008.09.012. Epub 2008 Sep 19.

PMID:
18845130
34.

Role of HIF-1 and NF-kappaB transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals.

Tacchini L, Gammella E, De Ponti C, Recalcati S, Cairo G.

J Biol Chem. 2008 Jul 25;283(30):20674-86. doi: 10.1074/jbc.M800365200. Epub 2008 Jun 2.

35.

Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells.

Alchera E, Tacchini L, Imarisio C, Dal Ponte C, De Ponti C, Gammella E, Cairo G, Albano E, Carini R.

Hepatology. 2008 Jul;48(1):230-9. doi: 10.1002/hep.22249.

PMID:
18506850
36.

Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver.

Dongiovanni P, Valenti L, Ludovica Fracanzani A, Gatti S, Cairo G, Fargion S.

Am J Pathol. 2008 Mar;172(3):738-47. doi: 10.2353/ajpath.2008.070097. Epub 2008 Feb 2.

37.

New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity.

Recalcati S, Invernizzi P, Arosio P, Cairo G.

J Autoimmun. 2008 Feb-Mar;30(1-2):84-9. doi: 10.1016/j.jaut.2007.11.003.

PMID:
18191543
38.

Iron-regulatory proteins: molecular biology and pathophysiological implications.

Cairo G, Recalcati S.

Expert Rev Mol Med. 2007 Dec 5;9(33):1-13. Review.

39.

An introduction to the metabolic determinants of anthracycline cardiotoxicity.

Menna P, Recalcati S, Cairo G, Minotti G.

Cardiovasc Toxicol. 2007;7(2):80-5. Review.

PMID:
17652809
40.

Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages.

De Ponti C, Carini R, Alchera E, Nitti MP, Locati M, Albano E, Cairo G, Tacchini L.

J Leukoc Biol. 2007 Aug;82(2):392-402. Epub 2007 May 15.

PMID:
17505024
41.

Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle.

Robach P, Cairo G, Gelfi C, Bernuzzi F, Pilegaard H, Viganò A, Santambrogio P, Cerretelli P, Calbet JA, Moutereau S, Lundby C.

Blood. 2007 Jun 1;109(11):4724-31. Epub 2007 Feb 20.

42.

Up regulation of IL-6 by ischemic preconditioning in normal and fatty rat livers: association with reduction of oxidative stress.

Tacchini L, Cairo G, De Ponti C, Massip M, Rosellò-Catafau J, Peralta C.

Free Radic Res. 2006 Nov;40(11):1206-17.

PMID:
17050174
43.

IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice.

Corna G, Galy B, Hentze MW, Cairo G.

J Mol Med (Berl). 2006 Jul;84(7):551-60. Epub 2006 Jun 13.

PMID:
16770644
44.

Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency.

Recalcati S, Alberghini A, Campanella A, Gianelli U, De Camilli E, Conte D, Cairo G.

Haematologica. 2006 Mar;91(3):303-10. Epub 2006 Feb 17.

45.

Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells.

Alberghini A, Recalcati S, Tacchini L, Santambrogio P, Campanella A, Cairo G.

J Biol Chem. 2005 Aug 26;280(34):30120-8. Epub 2005 Jun 28.

46.

Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload.

Montosi G, Corradini E, Garuti C, Barelli S, Recalcati S, Cairo G, Valli L, Pignatti E, Vecchi C, Ferrara F, Pietrangelo A.

Hepatology. 2005 Mar;41(3):545-52.

PMID:
15726660
47.

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.

Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L.

Pharmacol Rev. 2004 Jun;56(2):185-229. Review.

48.

Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms.

Minotti G, Recalcati S, Menna P, Salvatorelli E, Corna G, Cairo G.

Methods Enzymol. 2004;378:340-61. Review. No abstract available.

PMID:
15038979
49.

Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: role of reactive oxygen species and ferritin.

Corna G, Santambrogio P, Minotti G, Cairo G.

J Biol Chem. 2004 Apr 2;279(14):13738-45. Epub 2004 Jan 22.

50.

Blotting analysis of native IRP1: a novel approach to distinguish the different forms of IRP1 in cells and tissues.

Campanella A, Levi S, Cairo G, Biasiotto G, Arosio P.

Biochemistry. 2004 Jan 13;43(1):195-204.

PMID:
14705945

Supplemental Content

Support Center